ID
31306
Beschrijving
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Any adverse experience is defined as a new or worsening pre-existing medical condition or complication occurring while on study, regardless of its perceived relationship to the drug. Please record all adverse experiences from the time of study entry through the Week 13 visit.
Trefwoorden
Versies (1)
- 12-08-18 12-08-18 -
Houder van rechten
see clinicaltrials.gov
Geüploaded op
12 augustus 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Adverse Experiences
- StudyEvent: ODM
Beschrijving
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Beschrijving
Adverse Event; Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0237753
Beschrijving
Adverse Event
Datatype
text
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Adverse Event; CTC grade
Datatype
text
Alias
- UMLS CUI [1]
- C2985911
Beschrijving
Adverse event, serious
Datatype
boolean
Alias
- UMLS CUI [1]
- C1519255
Beschrijving
Adverse event; start date
Datatype
date
Alias
- UMLS CUI [1]
- C2697888
Beschrijving
Adverse event; end date
Datatype
date
Alias
- UMLS CUI [1]
- C2697886
Beschrijving
Adverse event; frequency
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439603
Beschrijving
Adverse event; Therapeutic Measures; Drugs
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0013227
Beschrijving
Adverse event; Therapeutic Measures; Other
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0205394
Beschrijving
Adverse event; Therapeutic Measures; Other; Specification
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C2348235
Beschrijving
Adverse event; Outcome
Datatype
text
Alias
- UMLS CUI [1]
- C1705586
Beschrijving
Adverse event; Relationship; Drug
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013227
Beschrijving
Adverse event; Relationship; Disease
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0012634
Similar models
Adverse Experiences
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0439849 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
Geen commentaren